Newsroom

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage pass-through certificates from CROSS 2026-NQM4 Mortgage Trust, an RMBS transaction issued under the CROSS shelf, where Hildene-CCC Loan Acquisition II, LLC and CrossCountry Capital are the co-sponsors. This $519.8 million transaction is collateralized by a pool of 904 residential mortgages, including a meaningful concentration of collateral that KBRA considers to be “non-prime” (78.3%), with fixed-rate mortga...

PAU, France--(BUSINESS WIRE)--Regulatory News: Arverne (FR001400JWR8 - ARVEN), 1er fournisseur français de solutions géothermales, annonce ses résultats annuels 2025. Pierre Brossollet, fondateur et Président Directeur Général d’Arverne, déclare : « Porté par un engagement collectif en faveur de la souveraineté énergétique française et européenne, à travers le développement de la chaleur et du lithium géothermals, Arverne crée une valeur durable au service des territoires et de la transition én...

PAU, France--(BUSINESS WIRE)--Regulatory News: Arverne (FR001400JWR8 – ARVEN), France’s leading provider of geothermal solutions, announces its 2025 annual results. Pierre Brossollet, Founder and Chief Executive Officer of Arverne, commented: “Driven by a collective commitment to French and European energy sovereignty, through the development of geothermal heat and geothermal lithium, Arverne is creating sustainable value in support of local communities and the energy transition. In 2025, the G...

AUSTIN, Texas & ARMONK, N.Y. & SAN FRANCISCO--(BUSINESS WIRE)--RSA 2026--CrowdStrike (NASDAQ: CRWD) and IBM today announced an expansion of their strategic collaboration to advance agentic SOC transformation. The expanded collaboration integrates CrowdStrike® Charlotte AI™ with IBM’s Autonomous Threat Operations Machine (ATOM), IBM’s autonomous SOC orchestration engine, for coordinated, machine-speed investigation and containment. It also extends the CrowdStrike Falcon® platform into IBM Consul...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired BlackRock TCP Capital Corp. (NASDAQ: TCPC) securities between November 6, 2024 and January 23, 2026. BlackRock TCP is a business development company that raises funds from investors and then uses those funds to make loans to small and midsize businesses as an alternative to bank financing. For more information, submit a form, email attorney Aa...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the alleg...

LOS ANGELES--(BUSINESS WIRE)--HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit with the Schall Law Firm...

HOUSTON--(BUSINESS WIRE)--Oceaneering Schedules First Quarter 2026 Earnings Release and Conference Call: April 22 and April 23, respectively....

CALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) announced today that its Board of Directors has declared quarterly dividends for the Company's preferred shares, Series 1, 3, 5, 7, 15, 17, 21 and 25. Series 1, 3, 5, 7, and 21 preferred share dividends are payable on June 1, 2026, to shareholders of record on May 1, 2026. Series 15 and 17 preferred share dividends are payable on June 30, 2026, to shareholders of record on June 15,...

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical-stage biopharmaceutical company that has developed innovative treatments for serious chronic diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic diseases (the "Company"), announces that it has signed, on March 25, 2026, the new Tranche D PDR subscription agreement with IPF Partners ("IPF"), for €3.75 million as part of th...